Hikma Recalls Buprenorphine Hydrochloride Injection Due to Low Potency
Hikma Pharmaceuticals is recalling 97,890 vials of Buprenorphine Hydrochloride Injection because stability testing revealed the drug was sub-potent.
- Product
- BUPRENORPHINE HYDROCHLORIDE — BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide